WPRIM Management System> DCMS> Chinese Journal of Urology> 2022> 43> 7

Volume: 43 Issue: 7

1. Progress of prostate cancer research at the 2022 American Urological Association annual meeting Page:481—483
2. Clinical analysis of prostate targeted biopsy guided by multiparametric magnetic resonance imaging and 68Ga-PSMA PET/CT image fusion Page:484—489
3. The preliminary study about feasibility and accuracy of the frozen section during targeted prostate biopsy Page:490—494
4. Clinical value of 68Ga-PSMA PET/CT in outpatient screening of prostate cancer Page:495—499
5. Efficacy of 68Ga-PSMA PET/CT in evaluating lymph node metastasis of prostate cancer Page:500—504
6. Feasibility of radical prostatectomy without biopsy for patients with highly suspected localized prostate cancer diagnosed by mpMRI and 68Ga-PSMA PET/CT Page:505—511
7. Analysis and interpretation of genetic testing results from 249 Chinese high to very-high risk non-metastatic prostate cancer patients Page:512—517
8. Clinical factors of positive surgical margin after robot-assisted laparoscopic radical prostatectomy in patients with high-risk prostate cancer Page:518—522
9. Influence of prostate cancer seminal vesicle invasion imaging classification on positive surgical margin after laparoscopic radical prostatectomy Page:523—528
10. Study of gonadotropin-releasing hormone antagonist in management of hormonal sensitive prostate cancer Page:529—534
11. Efficacy and safety of radium-223 in 48 patients with bone metastatic castration resistant prostate cancer Page:535—539
12. Efficacy and safety of radium-223 in the treatment of metastatic castration resistant prostate cancer Page:540—544
13. Therapeutic regimen with darolutamide for metastatic castration resistant prostate cancer: a case report Page:545—547
14. Research progress of nano-medical materials in the diagnosis and treatment of prostate cancer Page:548—551
15. Research progress of detection of lymph node metastases by 68Ga-PSMA PET in prostate cancer patients Page:552—554
16. Adjuvant or salvage radiotherapy in patients with adverse pathological features after radical prostatectomy Page:555—558

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.